Scientists say they've reversed brain aging with a simple nasal spray

Recorded: May 27, 2026, 3 a.m.

Original

Summarized

Scientists say they’ve reversed brain aging with a simple nasal spray | ScienceDaily

Your source for the latest research news

Follow:
Facebook
X/Twitter
Subscribe:
RSS Feeds
Newsletter

New! Sign up for our free email newsletter.

Science News
from research organizations

Scientists say they’ve reversed brain aging with a simple nasal spray
A simple nasal spray may one day help reverse brain aging, restore memory, and clear brain fog in just weeks.

Date:
May 26, 2026
Source:
Texas A&M University
Summary:
Researchers at Texas A&M have developed a nasal spray that appears to reverse brain aging by calming inflammation and restoring the brain’s energy systems. After just two doses, memory and cognitive function improved for months, raising hopes for future treatments targeting dementia and brain fog.
Share:

Facebook
Twitter
Pinterest
LinkedIN
Email

FULL STORY

Scientists at Texas A&M may have found a surprising way to turn back the clock on brain aging — with a simple nasal spray. Credit: Shutterstock

What if some of the mental decline linked to aging could actually be undone?

Researchers at Texas A&M University say they may have found a way to do just that using a simple nasal spray designed to reduce inflammation in the brain. In a new study, scientists reported that the treatment restored memory, reduced chronic inflammation, and improved brain cell function after just two doses.
The team believes the findings could eventually lead to new therapies for conditions tied to aging and cognitive decline, including dementia and Alzheimer's disease.
For years, scientists have known that aging brains often experience persistent low level inflammation, a process known as "neuroinflammaging." This chronic inflammation can interfere with memory, thinking, and the brain's ability to adapt to new situations. It is also considered a major contributor to neurodegenerative diseases.
Now, researchers say that process may not be permanent after all.
The study was led by Dr. Ashok Shetty, university distinguished professor and associate director of the Institute for Regenerative Medicine, together with senior research scientists Dr. Madhu Leelavathi Narayana and Dr. Maheedhar Kodali. Their findings were published in the Journal of Extracellular Vesicles.
"Brain age-related diseases like dementia are a major health concern worldwide," Shetty said. "What we're showing is brain aging can be reversed, to help people stay mentally sharp, socially engaged and free from age-related decline."
How the Experimental Nasal Spray Works

The therapy relies on microscopic biological particles called extracellular vesicles (EVs). These tiny structures naturally transport genetic material between cells. In this case, they were loaded with microRNAs, molecules that help regulate important biological processes in the brain.
"MicroRNAs act like master regulators," Narayana said. "They help modulate and regulate many gene and signaling pathways in the brain."
Researchers delivered the EVs through a nasal spray, allowing the treatment to bypass the brain's protective barrier and travel directly into brain tissue.
"The mode of delivery is one of the most exciting aspects of our approach," Kodali said. "Intranasal delivery allows us to reach, and treat, the brain directly without invasive procedures."
Once inside the brain, the treatment targeted immune cells involved in chronic inflammation. According to the researchers, the therapy suppressed inflammatory systems such as the NLRP3 inflammasome and the cGAS-STING signaling pathways, both of which are strongly linked to aging related brain inflammation.
Restoring the Brain's Cellular Energy
The treatment did more than simply reduce inflammation.

Scientists also found that it restored activity in mitochondria, the tiny structures inside cells responsible for producing energy. Aging and inflammation can damage mitochondria, leaving brain cells less efficient and more vulnerable to decline.
By improving mitochondrial function, the therapy appeared to help brain cells recover their ability to process and store information.
"We are giving neurons their spark back by reducing oxidative stress and reactivating the brain's mitochondria," Narayana said.
The improvements were not limited to biological measurements. Behavioral testing showed that treated models performed significantly better on memory and recognition tasks. They were more successful at identifying familiar objects, recognizing new ones, and detecting changes in their surroundings compared to untreated controls.
"We are seeing the brain's own repair systems switch on, healing inflammation and restoring itself," Shetty said.
Perhaps most notably, the effects appeared quickly and lasted for months after only two doses.
Potential Implications for Dementia and Brain Health
Researchers believe the approach could eventually have broad medical applications.
"As we develop and scale this therapy, a simple, two-dose nasal spray could one day replace invasive, risky procedures or maybe even months of medication," Shetty said.
The findings may be especially important as dementia rates continue to rise. In the United States, annual dementia cases are expected to increase from roughly 514,000 in 2020 to around 1 million by 2060.
"The trend signals a pressing need for policies and innovative interventions that can minimize both the risk and severity of neurodegenerative disorders like dementia," Shetty said.
The study also found similar treatment responses across both sexes, something researchers say is relatively uncommon in biomedical studies.
"It's universal," Shetty said. "Treatment outcomes were consistent and similar across both sexes."
In the future, the therapy could potentially help stroke patients recover brain function or slow cognitive decline linked to aging.
"Our approach redefines what it means to grow old," Shetty said. "We're aiming for successful brain aging: keeping people engaged, alert and connected. Not just living longer, but living smarter and healthier," Shetty said.
A New Direction for Brain Aging Research
The research was supported by the National Institute on Aging (NIA), and the team has already filed a U.S. patent related to the therapy.
According to Shetty, the goal is not only to understand the biology behind aging brains, but also to develop treatments that could eventually benefit patients.
"We aren't just trying to understand the biological mechanisms, we are translating and developing our findings into real-world therapies that could make a difference," Shetty said.
While additional research is still needed before the treatment could be tested in humans, the study offers a striking possibility: brain aging may not simply be an unavoidable part of getting older.
"Our partnership with the NIA is very important," Shetty said. "This kind of work requires resources and the right people to tackle problems and develop solutions that could change lives."

Top News

Human Quirks
Odd Creatures
Bizarre Things
Weird World

Keyword:Search

Free Subscriptions

Stay informed with ScienceDaily's free email newsletter, updated daily and weekly. Or view our many newsfeeds in your RSS reader:

Email Newsletter

RSS Feeds

Keep up to date with the latest news from ScienceDaily via social networks:

Facebook

X / Twitter

Have Feedback?

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?

Leave Feedback

Copyright 1995-2026 ScienceDaily or by other parties, where indicated. All rights controlled by their respective owners. Content on this website is for information only. It is not intended to provide medical or other professional advice. Views expressed here do not necessarily reflect those of ScienceDaily, contributors or partners. Financial support for ScienceDaily comes from advertisements and referral programs.

Researchers at Texas A&M University have investigated a nasal spray treatment that demonstrates the potential to reverse aspects of brain aging by addressing inflammation and restoring the brain's energy systems. The study reported that administering the treatment just two times resulted in improvements in memory and cognitive function that persisted for several months, fueling optimism for developing future treatments for conditions related to dementia and brain fog. This research addresses the long-standing understanding that aging brains suffer from persistent low-level inflammation, termed neuroinflammaging, which is implicated in cognitive decline and neurodegenerative diseases.

The therapeutic approach relies on extracellular vesicles (EVs), microscopic biological particles that naturally facilitate genetic material transport between cells. These EVs were loaded with microRNAs, which function as master regulators to modulate various gene and signaling pathways within the brain. The novel delivery method involved administering these EVs intranasally via a nasal spray, allowing the treatment to bypass the blood-brain barrier and access brain tissue directly without requiring invasive procedures.

Once within the brain, the treatment targeted specific inflammatory systems. The therapy successfully suppressed inflammatory pathways, including the NLRP3 inflammasome and the cGAS-STING signaling pathways, both of which are strongly associated with inflammation related to aging. Furthermore, the treatment focused on restoring cellular energy. Scientists observed that the intervention enhanced mitochondrial activity within brain cells, thereby combating the damage caused by aging and inflammation, which typically leaves brain cells less efficient. By improving mitochondrial function, the therapy helped neurons recover their capacity to process and store information by reducing oxidative stress and reactivating cellular energy production.

Behavioral testing corroborated the biological findings, showing that treated subjects exhibited significantly improved performance on memory and recognition tasks compared to untreated controls. The researchers noted that this improvement stemmed from the brain's intrinsic repair mechanisms activating, which healed inflammation and restored cellular function. The effects were observed to be rapid, with beneficial changes lasting for months following only two doses.

The implications of this work extend beyond immediate cognitive enhancement. Researchers postulate that this modality could eventually offer broad medical applications, potentially replacing invasive procedures or long-term medications for managing neurodegenerative disorders like Alzheimer's disease and dementia. The findings suggest a paradigm shift in the understanding of aging, aiming toward a state of "successful brain aging" characterized by alertness, engagement, and connection. Moreover, the study found consistent treatment responses across both sexes, suggesting a universal application for this therapeutic approach. As dementia rates are projected to rise, this research provides a pathway toward innovative interventions that can mitigate the risk and severity of neurodegenerative conditions. The work, supported by the National Institute on Aging, is focused on translating these biological mechanisms into tangible, real-world therapies.